Algert Global LLC Iovance Biotherapeutics, Inc. Transaction History

Algert Global LLC

$3.72 Billion
Q3 2024

A detailed history of Algert Global LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Algert Global LLC holds 54,070 shares of IOVA stock, worth $323,879. This represents 0.01% of its overall portfolio holdings.

Number of Shares

54,070

Previous 35,286 53.23%

Holding current value

$323,879

Previous $283,000 79.51%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$7.28 - $11.9 $136,747 - $223,529	18,784 Added 53.23%	54,070 $508,000
Q2 2024 Aug 14, 2024	SELL	$7.78 - $14.19 $27,167 - $49,551	-3,492 Reduced 9.01%	35,286 $283,000
Q1 2024 May 14, 2024	SELL	$7.59 - $17.47 $617,142 - $1.42 Million	-81,310 Reduced 67.71%	38,778 $575,000
Q4 2023 Feb 14, 2024	SELL	$3.3 - $8.89 $903,170 - $2.43 Million	-273,688 Reduced 69.5%	120,088 $976,000
Q3 2023 Nov 13, 2023	BUY	$4.44 - $8.79 $184,126 - $364,521	41,470 Added 11.77%	393,776 $1.79 Million
Q2 2023 Aug 14, 2023	SELL	$5.36 - $9.06 $336,109 - $568,125	-62,707 Reduced 15.11%	352,306 $2.48 Million
Q1 2023 May 12, 2023	BUY	$5.53 - $8.22 $130,618 - $194,156	23,620 Added 6.03%	415,013 $2.54 Million
Q4 2022 Feb 13, 2023	BUY	$5.62 - $10.0 $268,186 - $477,200	47,720 Added 13.89%	391,393 $2.5 Million
Q3 2022 Nov 15, 2022	BUY	$9.53 - $13.11 $1.7 Million - $2.34 Million	178,868 Added 108.53%	343,673 $3.29 Million
Q2 2022 Aug 15, 2022	BUY	$6.38 - $18.33 $746,632 - $2.15 Million	117,027 Added 244.94%	164,805 $1.82 Million
Q1 2022 May 16, 2022	BUY	$12.38 - $19.1 $141,169 - $217,797	11,403 Added 31.35%	47,778 $796,000
Q4 2021 Feb 14, 2022	BUY	$16.55 - $27.63 $41,987 - $70,097	2,537 Added 7.5%	36,375 $694,000
Q3 2021 Nov 15, 2021	BUY	$20.35 - $26.63 $414,895 - $542,932	20,388 Added 151.58%	33,838 $834,000
Q2 2021 Aug 13, 2021	BUY	$16.33 - $33.07 $219,638 - $444,791	13,450 New	13,450 $350,000
Q1 2021 May 14, 2021	SELL	$28.67 - $52.59 $333,174 - $611,148	-11,621 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$28.04 - $50.26 $325,852 - $584,071	11,621 New	11,621 $539,000
Q3 2020 Nov 16, 2020	SELL	$27.75 - $36.3 $853,506 - $1.12 Million	-30,757 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$27.21 - $41.0 $527,656 - $795,072	-19,392 Reduced 38.67%	30,757 $844,000
Q1 2020 May 13, 2020	BUY	$19.54 - $38.85 $510,736 - $1.02 Million	26,138 Added 108.86%	50,149 $1.5 Million
Q4 2019 Feb 18, 2020	BUY	$17.95 - $29.41 $430,997 - $706,163	24,011 New	24,011 $665,000
Q3 2019 Nov 14, 2019	SELL	$17.99 - $26.0 $235,309 - $340,080	-13,080 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$9.78 - $24.52 $127,922 - $320,721	13,080 New	13,080 $321,000

Others Institutions Holding IOVA

# of Institutions

319

Shares Held

239M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $945M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Account

Algert Global LLC Iovance Biotherapeutics, Inc. Transaction History